Extended-Release Intramuscular Naltrexone (VIVITROL®): A Review of Its Use in the Prevention of Relapse to Opioid Dependence in Detoxified Patients-Reference-Cited by-同舟云学术

Extended-Release Intramuscular Naltrexone (VIVITROL®): A Review of Its Use in the Prevention of Relapse to Opioid Dependence in Detoxified Patients

Published:2013-09-10 Issue:10 Volume:27 Page:851-861
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Syed Yahiya Y.,Keating Gillian M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology

Link

http://link.springer.com/content/pdf/10.1007/s40263-013-0110-x.pdf

Reference29 articles.

1. Tetrault JM, Fiellin DA. Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals. Drugs. 2012;72(2):217–28.

2. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: summary of national findings, NSDUH Series H-44, HHS publication no. (SMA) 12-4713. Rockville: Substance Abuse and Mental Health Services Administration; 2012.

3. Birnbaum HG, White AG, Schiller M, et al. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12(4):657–67.

4. World Health Organization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. 2009. http://www.who.int/substance_abuse/publications/opioid_dependence_guidelines.pdf . Accessed 22 May 2013.

5. Substance Abuse and Mental Health Services Administration. SAMHSA Advisory: an introduction to extended-release injectable naltrexone for the treatment of people with opioid dependence. 2012. http://store.samhsa.gov/shin/content//SMA12-4682/SMA12-4682.pdf . Accessed 7 Mar 2013.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Substance Use Disorders;Massachusetts General Hospital Comprehensive Clinical Psychiatry;2025

2. Attitudes toward extended-release naltrexone treatment for opioid use disorder among African Americans;Drug and Alcohol Dependence;2024-04

3. A Statement on the Pharmacology of Reinstatement: Naltrexone and Relapse to Opioid Seeking;Journal of Pharmacology and Experimental Therapeutics;2024-03-15

4. Novel Therapeutic and Program-Based Approaches to Opioid Use Disorders;Annual Review of Medicine;2024-01-29

5. Comparing outcomes of extended-release naltrexone in adolescents and young adults with opioid use disorder;Journal of Substance Use and Addiction Treatment;2023-09